Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Magaldrate

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 4Xls

    Filters

    clear-filterReset all filters
    2D Structure
    Also known as: 1317-26-6, Aluminum hydroxide/magnesium hydroxide, Aluminum hydroxide/magnesium hydroxide - magaldrate c410, Aluminum hydroxide/magnesium hydroxide - magaldrate c632
    Molecular Formula
    AlH3MgO2-
    Molecular Weight
    86.310  g/mol
    InChI Key
    SXSTVPXRZQQBKQ-UHFFFAOYSA-M
    Aluminum Hydroxide/Magnesium Hydroxide is an oral suspension containing aluminum hydroxide and magnesium hydroxide, with antacid effects. Aluminum hydroxide and magnesium hydroxide neutralizes or reduces gastric acid, thereby relieving symptoms associated with indigestion, gastritis, and gastroesophageal disease (GERD). Combined with other liquid ingredients (such as lidocaine and diphenhydramine), this antacid provides relief for painful stomatitis, mucositis, and esophagitis associated with both chemotherapy and radiation therapy.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 InChI
    InChI=1S/Al.Mg.2H2O/h;;2*1H2/p-1
    2.1.2 InChI Key
    SXSTVPXRZQQBKQ-UHFFFAOYSA-M
    2.1.3 Canonical SMILES
    O.[OH-].[Mg].[Al]
    2.2 Synonyms
    2.2.1 Depositor-Supplied Synonyms

    1. 1317-26-6

    2. Aluminum Hydroxide/magnesium Hydroxide

    3. Aluminum Hydroxide/magnesium Hydroxide - Magaldrate C410

    4. Aluminum Hydroxide/magnesium Hydroxide - Magaldrate C632

    2.3 Create Date
    2005-08-08
    3 Chemical and Physical Properties
    Molecular Weight 86.310 g/mol
    Molecular Formula AlH3MgO2-
    Hydrogen Bond Donor Count2
    Hydrogen Bond Acceptor Count2
    Rotatable Bond Count0
    Exact Mass85.9798844 g/mol
    Monoisotopic Mass85.9798844 g/mol
    Topological Polar Surface Area2 Ų
    Heavy Atom Count4
    Formal Charge-1
    Complexity0
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count4
    4 Pharmacology and Biochemistry
    4.1 ATC Code

    A02AD02

    S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355